Update on Andexanet Alfa for Reversal of FXa Inhibitors: Annexa-I Trial Webinar
59:31
Anticoagulants in Older Adults
16:12
Transthyretin Amyloid and New Treatment Options
23:07
DFWHC and Alexion webinar “Andexanet alfa Budget Impact Model”
59:20
Outpatient Anticoagulation Stewardship: Focusing on DOAC Management Models
11:36
Assads Elite-Einheiten auf der Flucht | BILD Lagezentrum
1:00:08
Women’s Health Considerations in Thrombosis Webinar
56:26
Navigating the 2024 PAD Guidelines
8:07